Choose a region: United States In 2023, around 40 percent of adults in the United States were obese, while 10 percent were severely obese. The rate of obesity has increased steadily over the past couple of deca
Age-adjusted incidence rates (per 100,000 population) were calculated across racial/ethnic groups, age cohorts, and US states. Descriptive statistics and confidence intervals were used to assess disparities.Results: Black, non-Hispanic individuals had the highest obesity-associated cancer incid...
In conclusion, our study findings suggest a negative correlation between the SUA/SCR ratio and the risk of cognitive impairment among older adults aged 60 and above in the United States. Further prospective studies are needed in the future to verify the potential mechanisms underlying this relationsh...
(Beverage Marketing Corporation). IBWA claimed that bottled water is the healthiest packaged beverage and is particularly crucial as the United States is faced with increased rates of obesity and diabetes. Despite continued growth and increased consumption, bottled water uses the least amount of ...
When we removed the prevalence of obesity, we found that MCL violation of PFHxS in UCMR5 was positively associated with cancers in the digestive system, detection of PFBA in UCMR5 was negatively associated with cancers of the skin and endocrine system, detection of PFOA in UCMR3 was positively...
January 2024: Eli Lilly and Company introduced LillyDirect, a digital healthcare platform designed to provide U.S. patients with obesity, migraine, and diabetes access to personalized disease management resources, healthcare providers, and home delivery of select Lilly medications through third-party ...
Prevalence of obesity in the United States, 2009-2010. NCHS Data Brief. 2012;(82):1-8.PubMedGoogle Scholar 8. Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA. 2012;307(5):491-497...
Forecast Period2022 - 2028 Estimated Market Value(USD)in 2022$23.32 Billion Forecasted Market Value(USD)by 2028$28.27 Billion Compound Annual Growth Rate3.2% Regions CoveredUnited States No. of Companies Mentioned13 Related Topics Antidiabetic
Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int J Obes Relat Metab Disord. 1998;22(1):39-47.PubMedGoogle ScholarCrossref 3. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA. 2010;303(...
The United States cardiometabolic fixed-dose combinations market is segmented into disease type and formulation type. By disease type, the market is segmented into hypertension, diabetes, dyslipidemia, and others. The other segments include conditions such as obesity and others. By formulation type...